Cargando…
Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy
The development of innovative targeted therapeutic approaches are expected to surpass the efficacy of current forms of treatments and cause less damage to healthy cells surrounding the tumor site. Since the first development of targeting agents from hybridoma’s, monoclonal antibodies (mAbs) have bee...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673844/ https://www.ncbi.nlm.nih.gov/pubmed/29163515 http://dx.doi.org/10.3389/fimmu.2017.01442 |